Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Terminated 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 4Fallopian Tube Neoplasms 3Stomach Neoplasms 2Peritoneal Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Cancer 1Neoplasm Metastasis 1Mesothelioma 1Colorectal Neoplasms 1Colorectal Cancer Metastatic 1

Interventions

Carboplatin 15Paclitaxel 13Hyperthermic Intraperitoneal Chemotherapy 6Cisplatin 5olaparib 4niraparib 4Bevacizumab 4oregovomab 3Topotecan 3Immunohistochemistry 3Gemcitabine 3Drug Therapy 3Docetaxel 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Amplified Fragment Length Polymorphism Analysis 3pembrolizumab 2liposomal doxorubicin 2anlotinib 2ST 1481 2Radiotherapy 2Polymerase Chain Reaction 2Oxaliplatin 2Neoadjuvant Therapy 2Gene Expression Profiling 2Fluorouracil 2Flow Cytometry 2Diathermy 2Cytoreduction Surgical Procedures 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Ovarian Epithelial × Cytoreduction Surgical Procedures × Clear all
NCT06223763 2024-01-25

SUROVA

Clinica Universidad de Navarra, Universidad de Navarra

Unknown
5,000 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03373058 2019-11-06

EHTASEOCCS

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Phase 3 Unknown
310 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡